Literature DB >> 15251984

Dual role of phagocytic NADPH oxidase in bacterial killing.

Balázs K Rada1, Miklós Geiszt, Krisztina Káldi, Csaba Timár, Erzsébet Ligeti.   

Abstract

The classical model of bacterial killing by phagocytic cells has been recently challenged by questioning the toxic effect of oxygen products and attributing the fundamental role to K(+) ions in releasing antimicrobial proteins within the phagosome. In the present study we followed O(2)(*-) production, changes of membrane potential, K(+) efflux, and bacterial killing in the presence of increasing concentrations of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor diphenylene iodonium. Efficiency of bacterial killing was assessed on the basis of bacterial survival measured by a new semiautomated method. Very low rates of O(2)(*-) production were accompanied by significant membrane depolarization and K(+) release and parallel improvement of bacterial killing. When O(2)(*-) production exceeded 20% of its maximal capacity, no further change was detected in the membrane potential and only minimal further K(+) efflux occurred, yet bacterial survival decreased parallel to the increase of O(2)(*-) production. The presented results indicate that both electrophysiological changes (depolarization and consequent ion movements) and the chemical effect of reactive oxygen species play a significant role in the killing of certain pathogens. The observation that an increase of membrane depolarization can compensate for decreased O(2)(*-) production may be important for potential therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15251984     DOI: 10.1182/blood-2004-03-1005

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  68 in total

1.  Regulation of Na+/H+ exchanger in dendritic cells by Akt2.

Authors:  Madhuri Bhandaru; Wenting Yang; Anand Rotte; Venkanna Pasham; Florian Lang
Journal:  Pflugers Arch       Date:  2011-09-28       Impact factor: 3.657

Review 2.  Electron and proton transport by NADPH oxidases.

Authors:  Nicolas Demaurex; Gábor L Petheö
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 3.  Consequences of the electrogenic function of the phagocytic NADPH oxidase.

Authors:  Balázs K Rada; Miklós Geiszt; Csilla Hably; Erzsébet Ligeti
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 4.  Philosophy of voltage-gated proton channels.

Authors:  Thomas E DeCoursey; Jonathan Hosler
Journal:  J R Soc Interface       Date:  2013-12-18       Impact factor: 4.118

Review 5.  Voltage-gated proton channels: what's next?

Authors:  Thomas E DeCoursey
Journal:  J Physiol       Date:  2008-09-18       Impact factor: 5.182

Review 6.  Role of Nox2 in elimination of microorganisms.

Authors:  Balázs Rada; Csilla Hably; András Meczner; Csaba Timár; Gergely Lakatos; Péter Enyedi; Erzsébet Ligeti
Journal:  Semin Immunopathol       Date:  2008-06-24       Impact factor: 9.623

Review 7.  Voltage-gated proton channels: molecular biology, physiology, and pathophysiology of the H(V) family.

Authors:  Thomas E DeCoursey
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 8.  Changing world of neutrophils.

Authors:  Csaba I Timár; Akos M Lőrincz; Erzsébet Ligeti
Journal:  Pflugers Arch       Date:  2013-05-01       Impact factor: 3.657

Review 9.  Microglial voltage-gated proton channel Hv1 in ischemic stroke.

Authors:  Long-Jun Wu
Journal:  Transl Stroke Res       Date:  2013-10-03       Impact factor: 6.829

10.  Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy.

Authors:  Christian Brendel; Walther Hänseler; Vital Wohlgensinger; Matteo Bianchi; Serap Tokmak; Linping Chen-Wichmann; Elena Kuzmenko; Nikola Cesarovic; Flora Nicholls; Janine Reichenbach; Reinhard Seger; Manuel Grez; Ulrich Siler
Journal:  Hum Gene Ther Methods       Date:  2013-05-02       Impact factor: 2.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.